Key Insights

Highlights

Success Rate

33% trial completion

Treatment Research

5 treatments under study, led by Constant Routine

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

66.7%

2 terminated out of 3 trials

Success Rate

33.3%

-53.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

33% success

Data Visualizations

Phase Distribution

Trial Status

Terminated2
Completed1

Trial Success Rate

33.3%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03956745Terminated

Biomarkers for Circadian Timing in Healthy Adults

NCT03980340Terminated

Breath Biomarkers for Sleep Loss and Circadian Timing

NCT04690504Completed

Validation of Circadian Biomarkers in Patients With Sleep Disorders

Showing all 3 trials

Research Network

Common Treatments

  • Constant Routine1
  • Dim Light Melatonin Onset Dlmo1
  • Short Nap Intervention1
  • No Nap Intervention1
  • Sleepwake Timing1

Active Sponsors

  • Brigham and Women's Hospital3
  • Stanford University2
  • Charite University, Berlin, Germany1

Top Investigators

Related Conditions

  • Delayed Sleep Phase Syndrome3
  • Sleep Disorders Circadian Rhythm3
  • Irregular Sleepwake Syndrome2
  • Shift Work Type Circadian Rhythm Sleep Disorder2
  • Delayed Sleep Phase2

Activity Timeline